{"id":"W2059255702","doi":"10.1007/s10637-014-0106-5","title":"A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients","year":2014,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Docetaxel; Dasatinib; Medicine; Prostate cancer; Oncology; Cancer; Internal medicine; Prostate; Pharmacology; Tyrosine kinase; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008217006,0.0002398707,0.0006676186,0.0004175951,0.0001009498,0.00002340029,0.00009749405,0.00007570307,0.00003745464],"category_scores_gemma":[0.0004295042,0.0001841388,0.0000524861,0.0007657736,0.0002539108,0.0002435173,0.00003287279,0.0002479117,0.000002185549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003381139,"about_ca_system_score_gemma":0.0008354865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003718333,"about_ca_topic_score_gemma":0.002994559,"domain_scores_codex":[0.9971137,0.000334924,0.0007899852,0.0004218995,0.001038915,0.0003005695],"domain_scores_gemma":[0.9985064,0.0003620045,0.0003290563,0.0002140488,0.0003889981,0.0001994922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8873422,0.009633924,0.05192629,0.0003552494,0.000367173,0.00005063537,0.03155755,0.0004001931,0.01301015,0.001590822,0.000498884,0.003266908],"study_design_scores_gemma":[0.9236452,0.008383076,0.0596059,0.0006461674,0.0001622288,8.226264e-7,0.0009596373,0.001094262,0.0038325,0.0013385,0.00009897174,0.0002327152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936897,0.0001427477,0.000005052048,0.001807286,0.0001041382,0.003448576,0.0000472467,0.00002469823,0.0007306088],"genre_scores_gemma":[0.9980111,0.00004058591,0.0003953163,0.00007127888,0.00006358523,0.0003926691,0.0004480804,0.00002818508,0.0005492102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03630299,"threshold_uncertainty_score":0.7508962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03335540329604145,"score_gpt":0.3297910892392198,"score_spread":0.2964356859431784,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}